• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型2-[2-(芳酰基)芳酰氧基]甲基-1,3,4-恶二唑的体外抗菌活性的合成与评价

Synthesis and evaluation of in vitro antimicrobial activity of novel 2-[2-(aroyl)aroyloxy]methyl-1,3,4-oxadiazoles.

作者信息

Girish V, Khanum Noor Fatima, Gurupadaswamy H D, Khanum Shaukath Ara

出版信息

Bioorg Khim. 2014 May-Jun;40(3):357-62.

PMID:25898743
Abstract

Synthetic pathway of the ten novel 2-[2-(aroyl)aroyloxy]methyl-1,3,4-oxadiazoles as new potential antimicrobial agents is illustrated. Intramolecular cyclization of 2-(2-aroylaryloxy) aceto hydrazides to 2-[2-(aroyl)aroyloxy]methyl-1,3,4-oxadiazoles was achieved with triethyl orthoformate in good yields. The compounds were characterized by IR, 1H NMR, mass spectra and by means of CHN analysis. The target compounds were tested for their in vitro antimicrobial activity against representative strains by disc diffusion method and micro dilution methods. Several compounds showed antimicrobial activity comparable with or higher than the standard drugs.

摘要

阐述了十种新型2-[2-(芳酰基)芳酰氧基]甲基-1,3,4-恶二唑作为新型潜在抗菌剂的合成途径。用原甲酸三乙酯使2-(2-芳酰基芳氧基)乙酰肼分子内环化生成2-[2-(芳酰基)芳酰氧基]甲基-1,3,4-恶二唑,产率良好。通过红外光谱、1H核磁共振、质谱以及元素分析对这些化合物进行了表征。采用纸片扩散法和微量稀释法对目标化合物针对代表性菌株的体外抗菌活性进行了测试。几种化合物显示出与标准药物相当或更高的抗菌活性。

相似文献

1
Synthesis and evaluation of in vitro antimicrobial activity of novel 2-[2-(aroyl)aroyloxy]methyl-1,3,4-oxadiazoles.新型2-[2-(芳酰基)芳酰氧基]甲基-1,3,4-恶二唑的体外抗菌活性的合成与评价
Bioorg Khim. 2014 May-Jun;40(3):357-62.
2
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.新型吡唑并[1,5-a] 1,3,4-噁二唑的合成、表征及抗菌活性评价。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):245-8. doi: 10.1016/j.bmcl.2013.11.029. Epub 2013 Nov 21.
3
Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.2-[1-(5-氯-2-甲氧基苯基)-5-甲基-1H-吡唑-4-基]-5-(取代苯基)-[1,3,4]恶二唑的合成、表征及抗菌活性。
Eur J Med Chem. 2009 Nov;44(11):4522-7. doi: 10.1016/j.ejmech.2009.06.020. Epub 2009 Jun 26.
4
Synthesis and antimicrobial activity of some 5-aryl-2-[N,N-disubstituted thiocarbamoylthio)acylamino]-1,3,4-oxadiazoles.一些5-芳基-2-[[N,N-二取代硫代氨基甲酰硫基)酰基氨基]-1,3,4-恶二唑的合成与抗菌活性
Farmaco. 1998 Aug-Sep;53(8-9):541-4. doi: 10.1016/s0014-827x(98)00063-9.
5
Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives.一些新型噁二唑衍生物的分子性质预测、合成及抗菌活性。
Eur J Med Chem. 2010 Dec;45(12):5862-9. doi: 10.1016/j.ejmech.2010.07.069. Epub 2010 Oct 1.
6
Synthesis and in vitro antimicrobial evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid.异烟肼的稠合杂环6-取代-1,2,4-三唑并-[3,4-b]-1,3,4-噻二唑和1,3,4-恶二唑衍生物的合成及体外抗菌评价
Acta Pol Pharm. 2011 Mar-Apr;68(2):205-11.
7
Hypervalent iodine(III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents.高价碘(III)介导的新型不对称 2,5-二取代 1,3,4-噁二唑的合成及其作为抗菌和抗真菌剂的应用。
Eur J Med Chem. 2010 Sep;45(9):4252-7. doi: 10.1016/j.ejmech.2010.06.023. Epub 2010 Jun 22.
8
New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation.基于新型 2-苄基硫基烟碱酸的 1,3,4-噁二唑衍生物的合成与生物评价。
Eur J Med Chem. 2013 Apr;62:677-87. doi: 10.1016/j.ejmech.2012.12.055. Epub 2013 Jan 23.
9
Synthesis and antimicrobial activity of novel sulfone-linked bis heterocycles.新型砜连接双杂环的合成与抗菌活性
Eur J Med Chem. 2008 May;43(5):917-24. doi: 10.1016/j.ejmech.2007.06.011. Epub 2007 Jul 6.
10
[Synthesis and antibacterial activity of 2-(3-pyridyl)-5-([(5-aryl-1,3,4-oxadiazol-2-yl) methylene]thio)-1,3,4-oxadiazoles].2-(3-吡啶基)-5-([(5-芳基-1,3,4-恶二唑-2-基)亚甲基]硫代)-1,3,4-恶二唑的合成及其抗菌活性
Yao Xue Xue Bao. 2004 Apr;39(4):263-5.